
SGLT2 inhibitors reduce AF recurrences in T2D patients post-ablation.


coremsg

Retrospective, observational data from more than 13,000 US patients with type 2 diabetes and atrial fibrillation suggest that SGLT2 inhibitor treatment may cut AF recurrences post-ablation.

SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in T2D

sglt2-inhibitors-reduce-af-recurrences-in-t2d-patients-post-ablation


SGLT2 Inhibitors Reduce AF Recurrences in T2D Patients Post-Ablation
